Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
| Country | United States |
|---|---|
| Deadline | Not published |
| Published | 2026-03-04 |
| Sectors | Health & life sciences |
| Source | Grants.gov (US) |
Summary
Funding opportunity PAR-26-132. CFDA: 93.866
The buyer, the value, the full description and the link to the official notice are available with a free account.